After an initial no, CHMP backs romosozumab for severe osteoporosis with high fracture risk; Baqsimi is the first nasally administered treatment for severe hypoglycemia.
International Approvals …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
